PDCD1 and neoplasm: We used a tumor-bearing mouse model to analyze the induction of PD1+ macrophages by tumor exosomes, and found that the tumor could induce PD1+ macrophage generation and that the exosome release inhibitor spiroepoxide could impair these effects (Fig. 5n, o).